← Back to Search

Device

Viscoeleastic delivery & trabeculotomy for Open-Angle Glaucoma

N/A
Recruiting
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female subjects, 22 years or older.
Visually significant cataract
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This study will prospectively assess the clinical effect of ab-interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with Cataract Extraction on intraocular pressure (IOP) and the use of IOP-lowering medications in patients with mild-moderate open angle glaucoma (OAG).

Eligible Conditions
  • Open-Angle Glaucoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in mean number of IOP-lowering medications
Change in mean unmedicated diurnal IOP
Secondary outcome measures
Percent of eyes with a ≥20% reduction in unmedicated diurnal IOP at 12 months
Percent of eyes with unmedicated diurnal IOP between 6 and 18 mmHg inclusive at 12 months
Other outcome measures
Safety Endpoint- Adverse events
Safety Endpoint- best corrected visual acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Viscoeleastic delivery & trabeculotomyExperimental Treatment1 Intervention
Patients with open angle glaucoma and cataract

Find a Location

Who is running the clinical trial?

Sight Sciences, Inc.Lead Sponsor
12 Previous Clinical Trials
795 Total Patients Enrolled
kavita p dhamdhere, MD, PhDStudy DirectorSight Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~36 spots leftby Mar 2025